Furanodiene enhances tamoxifen-induced growth inhibitory activity of ERa-positive breast cancer cells in a PPARγ independent manner

Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines

(2015) Rebecca J. McClaine et al.   NEOPLASIA

You never know: Cdk inhibitors as anti-cancer drugs

(2011) Tim Hunt   CELL CYCLE

Germacrone inhibits the proliferation of breast cancer cell lines by inducing cell cycle arrest and promoting apoptosis

(2011) Zhangfeng Zhong et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

(2011) Diana M Cittelly et al.   Molecular Cancer

Anti-cancer natural products isolated from chinese medicinal herbs

(2011) Wen Tan et al.   Chinese Medicine

New troglitazone derivatives devoid of PPARγ agonist activity display an increased antiproliferative effect in both hormone-dependent and hormone-independent breast cancer cell lines

(2010) Christelle Colin et al.   BREAST CANCER RESEARCH AND TREATMENT

A synthetic PPARγ ligand sensitizes breast cancer cells to tamoxifen-induced apoptosis.

(2010) Y Lee et al.   CANCER RESEARCH

Cyclin D1/Cyclin-Dependent Kinase 4 Interacts with Filamin A and Affects the Migration and Invasion Potential of Breast Cancer Cells

(2010) Z. Zhong et al.   CANCER RESEARCH

Cumulative alterations of p27Kip1-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma

(2010) Sohei Yamamoto et al.   HISTOPATHOLOGY

Curcumin enhances dasatinib-induced inhibition of growth and transformation of colon cancer cells

(2010) Jyoti Nautiyal et al.   INTERNATIONAL JOURNAL OF CANCER

An investigation of the ability of elemene to pass through the blood-brain barrier and its effect on brain carcinomas

(2010) Xue Shen Wu et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Antineoplastic effect ofβ-elemene on prostate cancer cells and other types of solid tumour cells

(2010) Qingdi Quentin Li et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

New therapeutic approaches in breast cancer

(2010) Eleri Davies et al.   MATURITAS

Potential Anti-Cancer Activities of Furanodiene, A Sesquiterpene from Curcuma wenyujin

(2009) Xiu-Yan Sun et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Troglitazone enhances tamoxifen-induced growth inhibitory activity of MCF-7 cells

(2008) Hong-Nu Yu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Induction of apoptosis by furanodiene in HL60 leukemia cells through activation of TNFR1 signaling pathway

(2008) Enlong Ma et al.   CANCER LETTERS

Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor γ (PPARγ) ligand

(2008) H YU et al.   CELL BIOLOGY INTERNATIONAL

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

(2008) N. Dhillon et al.   CLINICAL CANCER RESEARCH

Identification of Curcuma plants and curcumin content level by DNA polymorphisms in the trnS-trnfM intergenic spacer in chloroplast DNA

(2008) Motoyasu Minami et al.   Journal of Natural Medicines

Angiogenic effect of saponin extract fromPanax notoginsengon HUVECsin vitroand zebrafishin vivo

(2008) Si-Jia Hong et al.   PHYTOTHERAPY RESEARCH

Curcumin as “Curecumin”: From kitchen to clinic

(2007) Ajay Goel et al.   BIOCHEMICAL PHARMACOLOGY